Finance

Lists
CP60:FRA
Cooper Companies Inc
€56.15
+0.34%
(+0.19) 1D
Nov 16, 8:08:56 AM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CP60...
Open
€56.15
High
€56.15
Low
€56.15
Mkt. cap
11.91B
Avg. vol.
30.00
Volume
0.00
52-wk high
€74.50
52-wk low
€46.01
No. of employees
15K
Open
€56.15
High
€56.15
Low
€56.15
Mkt. cap
11.91B
Avg. vol.
30.00
Volume
0.00
52-wk high
€74.50
52-wk low
€46.01
No. of employees
15K
News stories
From web sources and news partners
Profile
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market. Wikipedia
About Cooper Companies Inc
CEOAlbert G. White III
Employees15K
Founded1958
HeadquartersPleasanton, California, United States
SectorHealth Care
IndustryMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
1.07B
1.02B
1.08B
1.07B
Cost of goods sold
414.30M
328.90M
346.10M
354.30M
Cost of revenue
414.30M
328.90M
346.10M
354.30M
Research and development expenses
41.40M
44.30M
42.50M
41.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415.40M
390.20M
676.20M
401.30M
Operating expense
506.60M
482.40M
766.40M
489.90M
Total operating expenses
920.90M
811.30M
1.11B
844.20M
Operating income
144.20M
212.80M
-31.00M
222.00M
Other non operating income
-16.40M
3.10M
4.30M
4.50M
EBT including unusual items
116.80M
192.20M
-48.40M
201.80M
EBT excluding unusual items
101.10M
192.20M
-48.40M
201.80M
Income tax expense
32.20M
61.40M
29.50M
-231.00M
Effective tax rate
27.57%
31.95%
-60.95%
-114.47%
Other operating expenses
-
-
-
-
Net income
84.60M
130.80M
-77.90M
432.80M
Net profit margin
7.94%
12.77%
-7.20%
40.59%
Earnings per share
1.15
1.10
1.21
1.15
Interest and investment income
-
-
-
-
Interest expense
-24.40M
-22.40M
-20.90M
-21.50M
Net interest expenses
-24.40M
-22.40M
-20.90M
-21.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
242.60M
308.30M
64.40M
316.70M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps